Published in J Gen Virol on February 01, 2002
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R. J Virol (2005) 1.44
Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J Virol (2003) 1.07
Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells. J Virol (2003) 1.00
MHV68 complement regulatory protein facilitates MHV68 replication in primary macrophages in a complement independent manner. Virology (2009) 0.96
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol (2009) 0.88
Rho'ing in and out of cells: viral interactions with Rho GTPase signaling. Small GTPases (2014) 0.78
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med (2005) 2.66
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J (2012) 1.75
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
Vaccinia virus morphogenesis and dissemination. Trends Microbiol (2008) 1.73
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol (2005) 1.70
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat Med (2006) 1.64
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A (2006) 1.62
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol (2002) 1.59
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol (2005) 1.52
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol (2005) 1.45
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol (2003) 1.43
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol (2002) 1.38
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol (2002) 1.36
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol (2003) 1.34
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol (2002) 1.33
Vaccinia virus cores are transported on microtubules. J Gen Virol (2003) 1.33
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol (2002) 1.30
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol (2006) 1.25
The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J Clin Invest (2010) 1.24
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog (2011) 1.22
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection. J Exp Med (2003) 1.19
A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog (2007) 1.17
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol (2006) 1.14
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol (2005) 1.12
How vaccinia virus has evolved to subvert the host immune response. J Struct Biol (2011) 1.11
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol (2002) 1.10
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol (2003) 1.07
Intradermal immune response after infection with Vaccinia virus. J Gen Virol (2006) 1.06
An investigation of incorporation of cellular antigens into vaccinia virus particles. J Gen Virol (2002) 1.05
Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog (2008) 1.04
Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol (2007) 1.03
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol (2008) 1.01
Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. J Gen Virol (2010) 1.00
Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog (2011) 1.00
The vaccinia virus soluble interferon-gamma receptor is a homodimer. J Gen Virol (2002) 0.99
Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist. J Biol Chem (2006) 0.99
A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. J Immunol (2003) 0.98
Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology (2002) 0.98
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol (2012) 0.97
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB. J Biol Chem (2011) 0.97
Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. PLoS Pathog (2010) 0.97
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J Gen Virol (2005) 0.95
Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus. Methods Mol Biol (2004) 0.94
B and CTL responses to the ALK protein in patients with ALK-positive ALCL. Int J Cancer (2006) 0.93
Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence. J Gen Virol (2007) 0.93
Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. J Gen Virol (2006) 0.92
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family. J Biol Chem (2012) 0.90
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response. J Gen Virol (2007) 0.89
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol (2008) 0.89
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol (2009) 0.88
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog (2013) 0.88
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes. J Immunol (2010) 0.87
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. J Gen Virol (2008) 0.86
A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol (2004) 0.86
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J Gen Virol (2004) 0.86
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol (2013) 0.86
The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence. J Gen Virol (2002) 0.85
Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. J Virol (2013) 0.85
A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A (2013) 0.84
hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. J Cell Biol (2013) 0.83
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation. J Gen Virol (2010) 0.80
Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1. J Gen Virol (2003) 0.80
Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein. J Gen Virol (2010) 0.80
Human and viral Golgi anti-apoptotic proteins (GAAPs) oligomerize via different mechanisms and monomeric GAAP inhibits apoptosis and modulates calcium. J Biol Chem (2013) 0.79
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions. J Gen Virol (2012) 0.78
Serological responses in humans to the smallpox vaccine LC16m8. J Gen Virol (2011) 0.77
Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. J Gen Virol (2006) 0.77
Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor. Immunology (2015) 0.77
Notes on transient host range selection for engineering vaccinia virus strain MVA. Biotechniques (2002) 0.76
The African swine fever virus protein j4R binds to the alpha chain of nascent polypeptide-associated complex. J Virol (2002) 0.76
Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein. J Gen Virol (2012) 0.76
[Rapid cell-to-cell spread: a story of jumping viruses]. Med Sci (Paris) (2010) 0.75